SH-526

N/A

Report date: 2022/07/15 17:50:46
NME

Base Information

Drug NameSH-526
Drug Alias NameSH-526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Sanhome Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Sanhome Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A